Literature DB >> 8946558

Arsenic-induced neural tube defects in mice: alterations in cell cycle gene expression.

B J Wlodarczyk1, G D Bennett, J A Calvin, R H Finnell.   

Abstract

The potential of arsenic to cause neural tube defects (NTD) in the human population remains a topic of controversy. While clearly toxic, the lack of well-defined human epidemiologic studies on this subject has made it difficult to fully understand the effects arsenic may have on the developing human neural tube. In the absence of good clinical data, we have tried to develop a murine model where hypotheses about the reproductive toxicity of arsenate can be tested. For these studies a murine strain (LM/Bc) that has proven to be susceptible to arsenic-induced NTD was use. Because cellular proliferation is vital for normal neural tube closure (NTC) to occur, in the present study we investigated whether an acute arsenate treatment could alter the expression of several cell cycle genes during murine neurulation. Pregnant LM/Bc dams were injected intraperitoneally on gestation day (GD) 7:12 (day:hour) and 8:12 with 40 mg/kg of arsenate, a treatment that causes exencephaly in 90 to 100% of the exposed fetuses. Neural tubes were then isolated from both control and arsenic treated embryos at GD 9:00, 9:12, 10:00, and 10:12, which encompasses all the stages of neurulation for this murine strain. Using the molecular techniques of in situ transcription and antisense RNA amplification (RT/aRNA) the expression pattern for bc1-2, p53, wee-1, and wnt-1 was analyzed at each of these time points. In the neural tubes isolated from control embryos, the expression of all four genes was significantly altered as neurulation progressed, demonstrating their developmental regulation. Following arsenate treatment, however, there was a significant upregulation in the expression of bc1-2 and p53 at gestational day 9:0, compared to their control values. The heightened expression of both of these genes suggests that arsenic inhibits cell proliferation, rather than inducing apoptosis, which delayed NTC and ultimately led to the neural tube defects observed in exposed embryos.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8946558     DOI: 10.1016/s0890-6238(96)00131-1

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  16 in total

Review 1.  Gene expression profiling within the developing neural tube.

Authors:  Richard H Finnell; Wade M Junker; Lisa Kvist Wadman; Robert M Cabrera
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

2.  Arsenic trioxide targets MTHFD1 and SUMO-dependent nuclear de novo thymidylate biosynthesis.

Authors:  Elena Kamynina; Erica R Lachenauer; Aislyn C DiRisio; Rebecca P Liebenthal; Martha S Field; Patrick J Stover
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-06       Impact factor: 11.205

Review 3.  Finding the genetic mechanisms of folate deficiency and neural tube defects-Leaving no stone unturned.

Authors:  Kit Sing Au; Tina O Findley; Hope Northrup
Journal:  Am J Med Genet A       Date:  2017-09-25       Impact factor: 2.802

4.  Mthfr gene ablation enhances susceptibility to arsenic prenatal toxicity.

Authors:  Bogdan J Wlodarczyk; Huiping Zhu; Richard H Finnell
Journal:  Toxicol Appl Pharmacol       Date:  2013-12-30       Impact factor: 4.219

5.  Low levels of arsenite activates nuclear factor-kappaB and activator protein-1 in immortalized mesencephalic cells.

Authors:  Kumar Felix; Sunil K Manna; Kimberly Wise; Johnny Barr; Govindarajan T Ramesh
Journal:  J Biochem Mol Toxicol       Date:  2005       Impact factor: 3.642

6.  Arsenic inhibits hedgehog signaling during P19 cell differentiation.

Authors:  Jui Tung Liu; Lisa J Bain
Journal:  Toxicol Appl Pharmacol       Date:  2014-10-30       Impact factor: 4.219

7.  Arsenic- and cadmium-induced toxicogenomic response in mouse embryos undergoing neurulation.

Authors:  Joshua F Robinson; Xiaozhong Yu; Estefania G Moreira; Sungwoo Hong; Elaine M Faustman
Journal:  Toxicol Appl Pharmacol       Date:  2010-09-29       Impact factor: 4.219

8.  Does arsenic increase the risk of neural tube defects among a highly exposed population? A new case-control study in Bangladesh.

Authors:  Maitreyi Mazumdar
Journal:  Birth Defects Res       Date:  2017-01-30       Impact factor: 2.344

9.  Impact of prenatal arsenate exposure on gene expression in a pure population of migratory cranial neural crest cells.

Authors:  Partha Mukhopadhyay; Ratnam S Seelan; Robert M Greene; M Michele Pisano
Journal:  Reprod Toxicol       Date:  2019-04-03       Impact factor: 3.143

10.  Inorganic arsenic as a developmental toxicant: in utero exposure and alterations in the developing rat lungs.

Authors:  Jay S Petrick; Francoise M Blachere; Ornella Selmin; Robert Clark Lantz
Journal:  Mol Nutr Food Res       Date:  2009-05       Impact factor: 5.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.